Galantamine
Back to searchMolecule Structure
Scientific Name
Galantamine
Description of the Drug
Galantamine is a cholinesterase inhibitor used to manage mild to moderate dementia associated with Alzheimer’s Disease.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00674
http://www.drugbank.ca/drugs/DB00674
Brand Name(s)
Acumor xl, Consion xl, Elmino xl, Galsya xl, Galzemic xl, Gatalin xl, Gazylan xl, Lotprosin xl, Luventa xl, Reminyl, Reminyl xl, Zeebral xl
Company Owner(s)
Impax Laboratories Inc, Sandoz Inc, Yabao Pharmaceutical Co Ltd Beijing, Watson Laboratories Inc, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Apotex Inc., Dr Reddys Laboratories Ltd, Mylan Pharmaceuticals Inc, Aurobindo Pharma Limited
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Acetylcholinesterase | SINGLE PROTEIN | INHIBITOR | CHEMBL220 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2577 | ||||
PharmGKB | PA449726 | ||||
Human Metabolome Database | HMDB0014812 | ||||
DrugBank | DB00674 | ||||
PubChem: Thomson Pharma | 14751181 | 14775584 | |||
PubChem | 9651 | ||||
Mcule | MCULE-7226205054 | MCULE-7156449246 | |||
NMRShiftDB | 20062583 | ||||
LINCS | LSM-5604 | ||||
Nikkaji | J11.407C | ||||
PDBe | GNT | ||||
BindingDB | 10404 | ||||
EPA CompTox Dashboard | DTXSID2045606 | ||||
DrugCentral | 1272 | ||||
Metabolights | MTBLC42944 | ||||
Brenda | 25855 | 17243 | 1391 | 70637 | 138752 |
ChemicalBook | CB8345888 | ||||
Guide to Pharmacology | 6693 | ||||
rxnorm | GALANTAMINE HYDROBROMIDE | GALANTAMINE | RAZADYNE | ||
KEGG Ligand | C08526 | ||||
ChEBI | 42944 | ||||
ZINC | ZINC000000491073 |